Announcements and Notices - [Other - Business Update]

Alphamab Oncology produces and sells drugs. The Company manufactures and sells tumor immunobiology macromolecular targeted drug and other products. Alphamab Oncology provides services worldwide.

Voluntary Announcement - Jskn003 Was Granted Breakthrough Therapy Designation
By The Fda For The Treatment Of Proc

Voluntary Announcement - Ind Application For Jskn027 Was Officially Accepted By The Cde

Next Day Disclosure Returns - [Share Buyback]

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Voluntary Announcement - Jskn003 Was Granted Breakthrough Therapy Designation By The Fda For The Treatment Of Proc

Voluntary Announcement - Ind Application For Jskn027 Was Officially Accepted By The Cde

Next Day Disclosure Return

Next Day Disclosure Return

Next Day Disclosure Return